Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Share Options and Director/PDMR Dealing

4 Aug 2022 07:00

RNS Number : 8451U
Quadrise Fuels International PLC
04 August 2022
 

4 August 2022

 

Quadrise Fuels International plc

("Quadrise", "QFI" or "the Company")

 

Issue of Share Options and Director/PDMR Dealing

 

Quadrise, the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels, announces the grant of an aggregate of 32,882,979 options to subscribe for new ordinary shares of 1p each in the Company ("Ordinary Shares") to directors and employees of the Company in accordance with the provisions of the Company's Unapproved Share Option Plan 2016 ("2016 Plan") and the Company's Enterprise Management Incentive Share Option Plan ("EMI Plan"), as appropriate (the "Options").

 

Of the Options, a total of 12,500,000 performance share options (the "Performance Options") have been awarded to executives of the Company, including awards to certain of the Company's directors and PDMRs in the amounts set out below.

 

The award of Performance Options to Jason Miles, Quadrise's Chief Executive Officer, follows a prior share options award to Mr. Miles on 3 September 2021 which will lapse unvested on the first anniversary of their grant date due to their specific performance conditions not having been met.

 

Director/PDMR

Number of Options

Plan

Exercise price

Jason Miles

7,500,000

2016 Plan

3.0p

David Scott

1,250,000

EMI Plan

3.0p

Philip Hill

1,000,000

EMI Plan

3.0p

Total

9,750,000

-

-

 

The Performance Options will vest as to 50% on the first anniversary of grant and the remaining 50% shall vest on the second anniversary of the date of grant. All vestings are subject to the satisfaction of specific performance conditions prior to the vesting dates.

 

The Performance Options awarded under the 2016 Plan will be exercisable from vesting until the eighth anniversary of the date of grant and the Performance Options awarded under the EMI Plan will be exercisable from vesting until the tenth anniversary of the date of grant.

 

In addition to the Performance Options, the Company has also granted a total of 14,000,000 additional Options to Non-Executive Directors of the Company in accordance with the provisions of the 2016 Plan, in the amounts set out below (the "Additional Options").

 

Director

Number of Options

Plan

Exercise price

Andrew Morrison

4,000,000

2016 Plan

3.0p

Laurie Mutch

4,000,000

2016 Plan

3.0p

Philip Snaith

4,000,000

2016 Plan

3.0p

Dilip Shah

2,000,000

2016 Plan

3.0p

Total

14,000,000

-

-

 

The Additional Options will vest as to 50% on the first anniversary of grant and the remaining 50% shall vest on the second anniversary of the date of grant and have no performance conditions to vesting attached. The Additional Options will be exercisable from vesting until the eighth anniversary of the date of grant. The vestings are not subject to the satisfaction of specific performance conditions.

 

The Company also announces the issue a total of 6,382,979 nominal value options ("NVOs") to certain of the Company's PDMRs and employees in lieu of cash bonuses for the financial year ended 30 June 2022. The NVOs have been issued in accordance with and under the EMI Plan. The issue of NVOs include the following awards to certain of the Company's PDMRs:

 

PDMR

Number of NVOs

Plan

Exercise price

David Scott

1,914,894

EMI Plan

 

1.0p

Philip Hill

212,766

EMI Plan

1.0p

Total

2,127,660

-

-

 

The NVOs will vest after 12 months from the date of grant, have no performance conditions and will be exercisable from vesting until the tenth anniversary of the date of grant.

 

Following the grant of the Performance Options, the Additional Options and the NVOs, the Company has a total of 61,871,770 options to subscribe for new Ordinary Shares in the Company under option, representing approximately 4.40% of the Company's current issued ordinary share capital. In addition, the Company has a further 40,223,716 Ordinary Shares under warrant, representing 2.86% of the Company's current issued ordinary share capital.

 

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provide further details.

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

 

Quadrise Fuels International Plc

Jason Miles, Chief Executive Officer +44 (0)20 7031 7321

David Scott, Head of Finance

Nominated Adviser

Cenkos Securities plc

Ben Jeynes +44 (0)20 7397 8900

Katy Birkin

 

Broker

Shore Capital Stockbrokers Limited

Toby Gibbs +44 (0)20 7408 4090

Fiona Conroy

 

Public & Investor Relations

Vigo Consulting

 Patrick D'Ancona +44 (0)20 7390 0230

Charlie Neish

 

 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of the Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Jason Miles

2. David Scott

3. David Scott

4. Philip Hill

5. Philip Hill

6. Andrew Morrison

7. Laurie Mutch

8. Philip Snaith

9. Dilip Shah

 

 

2

Reason for notification

a)

Position/Status

1. Chief Executive Officer

2. Head of Finance

3. Head of Finance

4. Chief Operating Officer

5. Chief Operating Officer

6. Non-Executive Chairman

7. Non-Executive Director

8. Non-Executive Director

9. Non-Executive Director

 

 

Initial notification/amendment

Initial notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Quadrise Fuels International plc

 

 

b)

LEI

213800HN2ETG5476U328

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 1 pence each

 

ISIN: GB00B11DDB67

 

 

b)

Nature of transaction

Awards of options to subscribe for new ordinary shares under the Quadrise Unapproved Share Option Plan 2016 and/or the Quadrise Enterprise Management Incentive Share Option Plan.

 

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

 

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

7. Nil

8. Nil

9. Nil

 

1. 7,500,000

2. 1,250,000

3. 1,914,894

4. 1,000,000

5. 212,766

6. 4,000,000

7. 4,000,000

8. 4,000,000

9. 2,000,000

 

 

d)

Aggregated information

 n/a

 

 

e)

Date of transaction

3 August 2022

 

 

f)

Place of transaction

Outside of a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUMGRUPPGMW
Date   Source Headline
13th Mar 20237:00 amRNSProposed Change of Name
6th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20237:00 amRNSWärtsilä Testing Update
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSMorocco Project Update
1st Feb 20237:00 amRNSBlock Admission Cancellation and Interim Review
31st Jan 20237:00 amRNSAppointment of New Auditor
30th Jan 20237:00 amRNSRe-Issue of Historical Share Options
16th Jan 20237:00 amRNSBusiness Update
29th Nov 20222:23 pmEQSQuadrise Fuels International (QFI): Key role in transitioning to net-zero
25th Nov 20222:16 pmRNSResult of AGM
25th Nov 20227:00 amRNSAGM Statement
23rd Nov 20227:00 amRNSPublication of Sustainability Report
15th Nov 20227:00 amRNSExtension of Exclusive Agreement with Nouryon
28th Oct 20224:48 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20227:00 amRNSFinal Results and Notice of AGM
21st Sep 20227:00 amRNSJoint Development Agreement with Vertoro
14th Sep 20227:00 amRNSNotice of Results and Investor Presentation
4th Aug 20227:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 202210:52 amRNSDirector/PDMR Dealing
1st Aug 20229:30 amRNSBlock Admission Interim Review
27th Jul 20227:00 amRNSFramework Agreement with MSC Shipmanagement
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 20225:40 pmRNSHolding(s) in Company
16th Jun 20227:00 amRNSIssue of Warrants
13th Jun 20227:30 amRNSMaterial Transfer & Cooperation Agreement
13th Jun 20227:00 amRNSAddendum to Representation Agreement
9th May 20227:00 amRNSOperational Update
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20228:28 amRNSCommercial Development Agreement with Valkor
28th Mar 20227:00 amRNSInterim Results
1st Feb 20223:00 pmRNSBlock Admission Interim Review
1st Feb 20228:44 amRNSReplacement:Appointment of Non-Executive Chairman
1st Feb 20227:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20227:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 202211:57 amRNSHolding(s) in Company
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAppointment of Chief Operating Officer
29th Dec 20214:42 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20215:05 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.